xenin 25: Clinical Trials

4 trials of xenin 25, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Withdrawn 1

Follow xenin 25: new trials by email Literature Review of xenin 25 trials Research Report on xenin 25

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
Control, Xenin-25 without atropine, GIP without atropine - Pre-diabetes
Phase 1CompletedWashington University School of Medicine152013-03-132018-05-25
Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy
Graded Glucose Infusion with Placebo, Graded Glucose Infusion with GIP Alone, Graded Glucose Infusion with xenin-25 alone - Does the Vagus Nerve Mediate the Effects of Xenin-25
Phase 1WithdrawnWashington University School of Medicine2013-01-012018-04-26
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Placebo, Glucose-dependent Insulinotropic Polypeptide (GIP), Xenin-25 - Type 2 Diabetes Mellitus
Phase 1CompletedWashington University School of Medicine382009-10-012014-07-22
Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus
Placebo, Glucose-dependent Insulinotropic Polypeptide (GIP), Xenin-25 - Diabetes
Phase 1CompletedWashington University School of Medicine402008-12-012018-05-03

Conditions studied

Insulin Resistance (3)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)

Sponsors

Washington University School of Medicine (4)

Countries

United States (4)

Top investigators

Dominic Reeds, MD (4)  ·  Burton M Wice, PhD (2)  ·  Burton Wice, PhD (2)

Results publications

PMID 22522617, PMID 24183983, PMID 24356886

NIH funding

1RC1DK086163-01 (1), R01DK088126 (1)